Impact of Definitive Drug-Drug Interaction Testing on Medication Management and Patient Care.

ABSTRACT:

Background and objective

Aegis Sciences Corporation developed a test (InterACT Rx^™) that objectively and definitively identifies substances known to interact with drug-drug interaction-prone medications commonly prescribed in the treatment of chronic pain and behavioral health disorders. The objective of this study was to assess the severity of identified drug-drug interactions, the reduction in the frequency and severity of identified drug-drug interactions, and the impact of the test on healthcare utilization.

Methods

Patients with chronic pain, behavioral health disorders, or both who had one or more drug-drug interaction tests and one or more drug-drug interactions identified in the study period were included. Drug-drug interaction test results described the n

SUBMITTER: Arnold RJG 

PROVIDER: S-EPMC6265235 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature